Abstract:Objective To investigate the inhibition effects of CpG oligodeoxynucleotide(CpG ODN) on renal carcinoma cell proliferation and tumor growth in vivo and in vitro,and explore the possible mechanism.Methods The effects of different concentrations of CpG ODN1826 and non-CpG ODN1982(ODN1982) interventions on proliferation of human renal clear cell carcinoma cell line Caki-1 cultured in vitro were determined with CCK-8 method.Tumor-bearing nude mouse models were established by subcutaneous implantation of Caki-1 cells into 24 BALB/c mice,and were randomly divided into control group(PBS),ODN1982 group(50 μg ODN1982),low-dose CpG ODN1826 group(25 μg CpG ODN1826) and high-dose CpG ODN1826 group(50 μg CpG ODN1826) 4 d later according to means of weekly treatment,with 6 mice in each group.Mice were sacrificed 35 d after model establishment,and changes of tumor volumes,tumor weight and tumor histology were compared among groups.Splenic lymphocytes of tumor-bearing mice in each group were isolated in vitro,and lactate dehydrogenase release method was employed to detect the cytolytic activity of splenic lymphocytes of tumor-bearing mice to tumor cells with different effector/target ratios(splenic lymphocytes:Caki-1 cells or splenic lymphocytes:YAC-1 cells).Results ODN1982 had no significant effect on in vitro proliferation of Caki-1 cells,while 500 μg/mL CpG ODN1826 significantly inhibited proliferation of Caki-1 cells.The tumor volumes of low-dose CpG ODN1826 group and high-dose CpG ODN1826 group were significantly smaller than those of control group and ODN1982 group at the end point of experiment(P 0.05),and there were significant differences in tumor weight among groups(P 0.05).It was revealed by histological observations that there were more inflammatory cell infiltration in low-dose CpG ODN1826 group and high-dose CpG ODN1826 group.The cytolytic activity of splenic lymphocytes of mice in high-dose CpG ODN1826 group to Caki-1 cells and YAC-1 cells was(9.74 ± 1.16) % and(79.65 ± 5.23) %,respectively at effector/target ratio of 50:1,and was significantly higher than that in control group [(7.67 ± 0.22) % and(10.12 ± 3.03) %,respectively] and ODN1982 group [(7.66 ± 0.93) % and(27.60 ± 9.83) %,respectively](P 0.05).Conclusion CpG ODN can inhibit renal carcinoma cell proliferation in vitro and tumor growth in tumor-bearing nude mice,and the mechanism may relate to the enhancement of innate immunity by CpG ODN.

Cytosine–phosphate–guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis

Pyrocatechol Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting ROS Production

CpG-oligodeoxynucleotides may be effective for preventing ionizing radiation induced pulmonary fibrosis.

Effects of CpG Oligodeoxynucleotide 1826 on Transforming Growth Factor-Beta 1 and Radiation-Induced Pulmonary Fibrosis in Mice

CpG Oligodeoxynucleotide Stimulates Protective Innate Immunity Against Human Renal Cell Carcinoma Xenografted in Nude Mice

Effects of CpG Oligodeoxynucleotide 1826 on Acute Radiation-Induced Lung Injury in Mice

Inhibition of EGFR Nuclear Translocation Attenuate Radioresistance Through Decreased P-Dna-pk Expression in Cervical Cancer Cells.

The Inhibition Of Egfr Nuclear Translocation Attenuates Radioresistance Through Decreasing The Expression Of P-Dna-Pk In Cervical Cancer Cells

Tetrahedral DNA Nanostructures Inhibit Ferroptosis and Apoptosis in Cisplatin-induced Renal Injury

Targeting OGG1 and PARG radiosensitises head and neck cancer cells to high-LET protons through complex DNA damage persistence

Ameliorating Effect of CpG-ODN (oligodeoxynucleotide) Against Radiation-Induced Lung Injury in Mice

Head and Neck Cancer Radiosensitization by the Novel Poly(Adp-Ribose) Polymerase Inhibitor Gpi-15427

In Vivo and in Vitro Study of Inhibition Effects of CpG Oligodeoxynucleotide on Renal Carcinoma Cell Proliferation and Tumor Growth

Enhancing Radiosensitivity of Human Pulmonary Adenocarcinoma Cell Line A549 by Cpg Odn1826

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Triple Kill: DDR Inhibitors, Radiotherapy and Immunotherapy Leave Cancer Cells with No Escape

Combined Olaparib and Oxaliplatin Inhibits Tumor Proliferation by Cell Cycle Arrest and Cell Apoptosis in XRCC2-defecient Colorectal Cancer

Combined Olaparib and Oxaliplatin Inhibits Tumor Proliferation and Induces G(2)/M Arrest and Gamma-H2ax Foci Formation in Colorectal Cancer

Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation

Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.

Effect of C- Erbb2 Antisense Oligodexynucleotides on Radiosensitivity of Human Ovarian Cancer Cell Line